Project Description

Invited Expert Interview
Interview with: Rachel E. Sanborn, MD
Interview date: June 1, 2020
Disclosures: Consulting or Advisory Role: Amgen, Seattle Genetics, Peregrine Pharmaceuticals, ARIAD, Genentech/Roche, AstraZeneca, Celldex, Abbvie, Takeda; Honoraria: AstraZeneca, Amgen; Research Funding: Bristol-Myers Squibb, MedImmune, Merck; Travel, Accommodations, Expenses: Five Prime Therapeutics, Janssen Oncology, AstraZeneca
Affiliations: Co-Director, Thoracic Oncology Program; Director, Phase I Clinical Trials Program, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute
Subtitles/Captions:

Disclaimer: Springer Healthcare selected the experts for interview. The expert interviews appearing herein were not prepared or reviewed by ASCO and have not been subject to a peer review process. The ideas and opinions expressed herein do not necessarily reflect those of ASCO. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. Full disclaimer.

© 2020 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

Subtitles:
Loading...
Invited Expert Interview
Interview with: Rachel E. Sanborn, MD
Interview date: June 1, 2020
Disclosures: Consulting or Advisory Role: Amgen, Seattle Genetics, Peregrine Pharmaceuticals, ARIAD, Genentech/Roche, AstraZeneca, Celldex, Abbvie, Takeda; Honoraria: AstraZeneca, Amgen; Research Funding: Bristol-Myers Squibb, MedImmune, Merck; Travel, Accommodations, Expenses: Five Prime Therapeutics, Janssen Oncology, AstraZeneca
Affiliations: Co-Director, Thoracic Oncology Program; Director, Phase I Clinical Trials Program, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute
Subtitles/Captions:

Disclaimer: Springer Healthcare selected the experts for interview. The expert interviews appearing herein were not prepared or reviewed by ASCO and have not been subject to a peer review process. The ideas and opinions expressed herein do not necessarily reflect those of ASCO. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. Full disclaimer.

© 2020 American Society of Clinical Oncology (ASCO®). All Rights Reserved.